Vincent Servois is a Doctor of Medicine, former resident and chief resident in Paris hospitals. Specialist practitioner in cancer treatment centers. Postgraduate diploma in “Radiodiagnosis and Medical Imaging”. Advanced postgraduate diploma in Medical Imaging. Diploma in Interventional radiology.
He specializes in general oncological radiology (excluding senology): digestive, urinary tract-genital, melanoma). Interventional radiology. Clinical trial assessment. Translational research.
After his medical studies and specialization in medical imaging, Dr Servois conducted postgraduate research in the laboratory of JM Lhoste (Institut Curie in vivo NMR laboratory - Orsay (INSERM U.350)). He rapidly decided to specialize exclusively in oncology, joining the medical department of Institut Curie where he was appointed full-time specialist practitioner in 1992.
Since then, his clinical activity focuses mainly on digestive disease, genital-urinary disease and uveal melanoma. For many years he has also been closely involved in diagnostic and therapeutic interventional radiology and is currently in charge of the interventional radiology unit (excluding senology) at the Paris site.
Convinced of the strength of different complementary disciplines in fighting cancer, Dr Servois has always favored working with colleagues with other specialties such as surgeons or oncological radiotherapists to better integrate imaging data in the application of local treatments.
Part of his clinical activity is also devoted to assessing the efficacy of treatments. He contributed greatly to setting up an organization to rapidly assess therapy trials according to international standards.
As well as his clinical activity, he is also involved in translational research. For his research, he has fostered special links with teams at the Institut Langevin - ESPCI Paris Tech since 2005.
For this, Dr Servois is currently working on developing a new imagery technique that combines acoustic (ultrasound) and optical data known as acousto-optics and is hoping to use this to better detect and characterize melanoma and other tumors.
He is the author and co-author of 224 communications/publications including 90 PubMed references with a h-index of 24 and is co-inventor of a patent.